Optimal and safe standard doses of midazolam and propofol to achieve patient and doctor satisfaction with dental treatment: A prospective cohort study.
<h4>Background</h4>The incidences of morbidity and mortality caused by pharmacosedation for dental treatment have not yet reached zero. Adverse events are related to inappropriate respiratory management, mostly originating from an overdose of sedatives. Since sedation is utilized for the...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0171627&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850230391289413632 |
|---|---|
| author | Rikuo Masuda Mutsumi Nonaka Akiko Nishimura Kinuko Gotoh Shuichirou Oka Takehiko Iijima |
| author_facet | Rikuo Masuda Mutsumi Nonaka Akiko Nishimura Kinuko Gotoh Shuichirou Oka Takehiko Iijima |
| author_sort | Rikuo Masuda |
| collection | DOAJ |
| description | <h4>Background</h4>The incidences of morbidity and mortality caused by pharmacosedation for dental treatment have not yet reached zero. Adverse events are related to inappropriate respiratory management, mostly originating from an overdose of sedatives. Since sedation is utilized for the satisfaction of both the dentist and the patient, the optimal dose should be minimized to prevent adverse events. We attempted to define the optimal doses of midazolam and propofol required to achieve high levels of patient and dentist satisfaction.<h4>Methods</h4>One thousand dental patients, including those undergoing third molar extractions, were enrolled in this study. A dose of 1 mg of midazolam was administered at 1-minute intervals until adequate sedation was achieved. Propofol was then infused continuously to maintain the sedation level. Both the patients and the dentists were subsequently interviewed and asked to complete a questionnaire. A multivariate logistic regression analysis was used to examine the factors that contributed to patient and dentist satisfaction.<h4>Results</h4>The peak midazolam dose resulting in the highest percentage of patient satisfaction was 3 mg. Both a lower dose and a higher dose reduced patient satisfaction. Patient satisfaction increased with an increasing dosage of propofol up until 4 mg/kg/hr, reaching a peak of 78.6%. The peak midazolam dose resulting in the highest percentage of dentist satisfaction (78.8%) was 2 mg. Incremental propofol doses reduced dentist satisfaction, in contrast to their effect on patient satisfaction. The strongest independent predictors of patient satisfaction and dentist satisfaction were no intraoperative memory (OR, 5.073; 95% CI, 3.532-7.287; P<0.001) and unintentional movements by the patient (OR, 0.035; 95% CI, 0.012-0.104; P<0.001), respectively. No serious adverse events were reported.<h4>Conclusion</h4>We found that 3 mg of midazolam and 3 mg/kg/hr of propofol may be the optimal doses for maximizing both patient and dentist satisfaction. Although this level of sedation is relatively light, memory loss and an absence of unintentional patient movements can be expected without adverse events. |
| format | Article |
| id | doaj-art-99599daf2d1e4ad081ad9c5ce417210b |
| institution | OA Journals |
| issn | 1932-6203 |
| language | English |
| publishDate | 2017-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-99599daf2d1e4ad081ad9c5ce417210b2025-08-20T02:03:54ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01122e017162710.1371/journal.pone.0171627Optimal and safe standard doses of midazolam and propofol to achieve patient and doctor satisfaction with dental treatment: A prospective cohort study.Rikuo MasudaMutsumi NonakaAkiko NishimuraKinuko GotohShuichirou OkaTakehiko Iijima<h4>Background</h4>The incidences of morbidity and mortality caused by pharmacosedation for dental treatment have not yet reached zero. Adverse events are related to inappropriate respiratory management, mostly originating from an overdose of sedatives. Since sedation is utilized for the satisfaction of both the dentist and the patient, the optimal dose should be minimized to prevent adverse events. We attempted to define the optimal doses of midazolam and propofol required to achieve high levels of patient and dentist satisfaction.<h4>Methods</h4>One thousand dental patients, including those undergoing third molar extractions, were enrolled in this study. A dose of 1 mg of midazolam was administered at 1-minute intervals until adequate sedation was achieved. Propofol was then infused continuously to maintain the sedation level. Both the patients and the dentists were subsequently interviewed and asked to complete a questionnaire. A multivariate logistic regression analysis was used to examine the factors that contributed to patient and dentist satisfaction.<h4>Results</h4>The peak midazolam dose resulting in the highest percentage of patient satisfaction was 3 mg. Both a lower dose and a higher dose reduced patient satisfaction. Patient satisfaction increased with an increasing dosage of propofol up until 4 mg/kg/hr, reaching a peak of 78.6%. The peak midazolam dose resulting in the highest percentage of dentist satisfaction (78.8%) was 2 mg. Incremental propofol doses reduced dentist satisfaction, in contrast to their effect on patient satisfaction. The strongest independent predictors of patient satisfaction and dentist satisfaction were no intraoperative memory (OR, 5.073; 95% CI, 3.532-7.287; P<0.001) and unintentional movements by the patient (OR, 0.035; 95% CI, 0.012-0.104; P<0.001), respectively. No serious adverse events were reported.<h4>Conclusion</h4>We found that 3 mg of midazolam and 3 mg/kg/hr of propofol may be the optimal doses for maximizing both patient and dentist satisfaction. Although this level of sedation is relatively light, memory loss and an absence of unintentional patient movements can be expected without adverse events.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0171627&type=printable |
| spellingShingle | Rikuo Masuda Mutsumi Nonaka Akiko Nishimura Kinuko Gotoh Shuichirou Oka Takehiko Iijima Optimal and safe standard doses of midazolam and propofol to achieve patient and doctor satisfaction with dental treatment: A prospective cohort study. PLoS ONE |
| title | Optimal and safe standard doses of midazolam and propofol to achieve patient and doctor satisfaction with dental treatment: A prospective cohort study. |
| title_full | Optimal and safe standard doses of midazolam and propofol to achieve patient and doctor satisfaction with dental treatment: A prospective cohort study. |
| title_fullStr | Optimal and safe standard doses of midazolam and propofol to achieve patient and doctor satisfaction with dental treatment: A prospective cohort study. |
| title_full_unstemmed | Optimal and safe standard doses of midazolam and propofol to achieve patient and doctor satisfaction with dental treatment: A prospective cohort study. |
| title_short | Optimal and safe standard doses of midazolam and propofol to achieve patient and doctor satisfaction with dental treatment: A prospective cohort study. |
| title_sort | optimal and safe standard doses of midazolam and propofol to achieve patient and doctor satisfaction with dental treatment a prospective cohort study |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0171627&type=printable |
| work_keys_str_mv | AT rikuomasuda optimalandsafestandarddosesofmidazolamandpropofoltoachievepatientanddoctorsatisfactionwithdentaltreatmentaprospectivecohortstudy AT mutsuminonaka optimalandsafestandarddosesofmidazolamandpropofoltoachievepatientanddoctorsatisfactionwithdentaltreatmentaprospectivecohortstudy AT akikonishimura optimalandsafestandarddosesofmidazolamandpropofoltoachievepatientanddoctorsatisfactionwithdentaltreatmentaprospectivecohortstudy AT kinukogotoh optimalandsafestandarddosesofmidazolamandpropofoltoachievepatientanddoctorsatisfactionwithdentaltreatmentaprospectivecohortstudy AT shuichirouoka optimalandsafestandarddosesofmidazolamandpropofoltoachievepatientanddoctorsatisfactionwithdentaltreatmentaprospectivecohortstudy AT takehikoiijima optimalandsafestandarddosesofmidazolamandpropofoltoachievepatientanddoctorsatisfactionwithdentaltreatmentaprospectivecohortstudy |